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Isolated protein kinase C (PKC) was irreversibly inactivated by a brief (mm) incubation with calphoatin C in the prc~en~ of light, This inactivation 
required Ca"* either in a mdhmolar range in the absenc ,~of lipid activators or in a submicrornolar range in the pre~nce of lipid activators. In 
addition, an oxygen atmosphere web required suggestmt~' theinvolvement of oxidation(s) inthis inactivation process. Furthermore, laKC inactivation 
might involve a site-specific ox~dative modification of the enzyme at the CaZ*-mduced hydrophob~c region, lahysical queneher~ of singlet oxygen 
such as lycopene, fl.carotene, and =-tocopherol all reduced the calphostm C-induced inactivation of PKC. In intact cells treated with calphostm 
C, the iaaetivalion of laKC was rapid in the membrane fraction compar~:l to cytosol. Thin intrecellular PKC inactivation was also found to 
irreversibl~. Therefore, calphostin C can bring prolonged effects for several hours in cells treated for a short time. Taken together the~e rest,Its 
sugl3est that the calphostm C-mediated inactivation of PKC involves a site-specific and a "cage' type oxidative modification of lake. 
Protein km;ise C; Reactive oxygen species, Singlet oxygen; Calpho~tm C; O~:ldative modd~eation; Ca~-+-induced hydrophobie r gion 
1. INTRODUCTION 
Protein kinase C (PKC) has been implicated to play 
a key role in signal transduction and also in tumor 
promotion [1-3]. Terpenoid tumor promoters uch as 
phorbol esters induce not only the activation of PKC by 
direct binding to the enzyme but also the downregula- 
tion of PKC by an indirect mechanism [1-5]. Oxidant 
tumor promoters either activate or inactivate PKC de- 
pending on the extent of oxidative modification [6-8]. 
A selective oxidative modification of  the regulatory do- 
main results in a Ca2*/lipid-independent ac ivation of 
the kinase with a loss of phorbol ester binding [6]. Alter- 
nately, a selective oxidative modification of the kinase 
domain results in the generation of  a modified form of 
PKC which exhibits only phorbol ester binding [8]. 
Some oxidants uch as H20, induce irreversible oxida- 
tive modification [6], whereas others such as m-peri- 
odate induce reversible oxidative modification [8]. Fur- 
thermore, PKC (the phorbol ester receptor) was shown 
to be regulated by lipid peroxidation [9], redoxy cycling 
quinones [10], and oxidant-generating systems [11]. 
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Abbrevfattons. PKC, protein kgnase C; EGTA, ethylene glycol bin(fl- 
ammoethylether).N,N'-tetraaeette cid; laDBu, phorbol 12,13-dibu- 
tyrate; TPA, 12-O-tctradeeanoyl-phorbol 13-acetate. 
Since reactive oxygen species have been implicated in 
various disease states [12], PKC may be oxidatively reg- 
ulated under these pathophysiological onditio~ts. 
Agents that selectively inhibit PKC are desirable tools 
to assess the role of  PKC in various cellular functions 
and also as therapeutic agents. Furthermore, under- 
standing the mechanism of action of  such agents is im- 
portant o design and develop more specific inhibitors. 
There have been two types of PKC inhibitors reported: 
one binds to the regulatory domain and the other binds 
to the catalytic domain [13-15]. Calphostin C is a 
perylenequinone metabolite isolated from the fungus 
Cladosporium cladosporioides [16]. It is one of the spe- 
cific inhibitors of PKC and it inhibits both phorbol ester 
binding and phosphotranstbrase ctivity of  PKC pre- 
sumably by binding to tile regulatory domain [16]. 
Moreover, the inhibition of PKC by calphostin C is 
light dependent [17]. Although calphostin C has been 
extensively employed as a pharmacological tool, the 
mechanism of its action is not elucidated. It is not 
known whether the light-reaction products of cal- 
phostin C induced a reversible inhibition by binding to 
PKC. Alternately, an irreversible inactivation may be 
induced by either oxidative modification of  the amino 
acid residues within PKC, or by a covalent interaction 
of calphostin C with the enzyme. Since we have been 
involved in understanding the regulation of  PKC by 
oxidations, we have attempted todetermine the possible 
involvement of oxidations in calphostin C-mediated in- 
hibitions of PKC. Our results uggested that calphostin 
C induced a site-specific oxidative modification of  PKC 
at the Ca2*-ir, dueed hydrophobic region. This resulted 
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in an irreversible inact ivat ion of  PKC both  in the iso- 
lated fo rm and in intact cells. 
2. MATERIALS  AND METHODS 
2.1 Mate~tal~ 
Calphostm C was purchased from the LC Services Corporation. 
B-Carotene and DL-CZ-tocopherol were obtained from Fluka Lycopene 
and N-acetylcystei,~e w re supplied by the Sigma Chemical Company. 
PKC flora rat brain was purified to apparent homogeneity as de- 
scribed previously [18]. In some experiments parti.'dly purified PKC 
(approximately 600 units/rag protein) was used. M-kinase wa~ derived 
from native PKC by limited proteolysis using calpam 1I as described 
previously [6]. 
2 2 PKC tretmnent with calphostm C 
Although PKC at vat ions stages of purification exhibited sensitivity 
to calpho~tm C-mediated inhibition, PKC in freshly purified prepara- 
tions was completely inhibited by ealpho~tln C. Purified PKC (2 unit~) 
was incubated with calphostm C along w~th various factors in a total 
volume of 0 5 ml m polystyrene tubes at room temperature under 
ordinary fluorescent light for 3 rain Then, 25 pl of bovine ~erum 
albumin solution (10 md/mi)and 25 al of 0.1 M EDTA were added. 
Calphostin C and other low-molecular-weight compounds were re- 
moved from the treated PKC samples by subjecting them to a "centri- 
fuge column techmqae' [19l. 
2.3. lsol¢ttion of PKC from calphost/n.t~eated c lh 
The e)'tosohc and delergent-solubdmed membrane fractmns were 
prepared from control and ealphostm C-treated cells a~ described 
previously [18]. These fractions (2.5 ml) were applied to 0.5-ml DEAE- 
cellulose (DE-52) columns previously equilibrated with buffer A (20 
mM Tr]s-HCI, pH 7.5/1 mM EDTA/0.1 mM DTT). After washing the 
column with 2 ml of buffer A, the bound PKC was eluted with 1 25 
ml of 0 1 M NaCI in buffer A. 
2.4 PKC asaav and PDBu binding 
Both PKC phosphotransferase etiwt~, and phorbol estel' binding 
were determined by usmga multiwell plate filtration assay utihzing the 
MultiScreen system (Milliporc) as described elsewhere [20]. Brielly, 
PKC reaction -~amples in a total volume of 125 al were incubated in 
96-well plate~ with fitted filtration disen made of cellulose acetate 
membranes (HA type). The histone H 1 was precipitate" and filtered 
with 10% TCA and the radioacttwty a~soeiated with the filters wa~ 
counted. Similarly, for the detemaination f PKC-assoeiated phorbol 
ester binding, both incubations and filtrations were carried out in 
muir=well plates fitted with filtration discs The sample ~, were incu- 
bated with [aH]phorbol 12,13-dibutyrate (PDBu) in the microwclls, the 
ligand-bound PKC wa~ adsorbed onto DEAE-Sephadex beads, and 
the beadn then were filtered and washed in the same multiwells. The 
radtoactivlty associated with the DEAE-Sephadex beads retained on 
the filter was counted. PKC activity wa~ expressed as un=ts, where one 
unit of enzyme transfers 1nmol of phosphate to hlstone HI per min 
at 30°C. 
3. RESULTS 
In prev ious studies, ca lphost in  C was  added directly 
to the kinase assay or  to the PDBu b ind ing  incubat ion 
to  determine  its effect on  PKC [15,16]. Since the PKC 
assay mixture  conta ins  var ious  other  components ,  it is 
very d i~cu! t  to determine  the factors  that  influence the 
act ion o f  ca lphost in  C. Fur thermore ,  it is a lso dil'ficult 
to  dist inguish whether  ca lphost in  C is induc ing an inhi- 
b it ion or  a permanent  inact ivat ion o f  PKC.  Therefore,  
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Fig. 1. Ca 2. requirement for inactivation of PKC by calphostin C. 
Purified PKC samples were treated with calphostm C (1 ltM) in the 
presence of light. The indicated concentrations of free Ca ~+ wei e mare. 
tained by using EGTA-CaCI~ buffer. To one bet of sample~ (open 
symbols) no lipid activators were added, whereas to the other set of 
mamples (filled symbols) 10 big of phosphatidylserme and 0.4/t~ of 
dLolein were added In the samples incubated with hpids there was a 
need to add ATP (0.1 raM) and M~ + (8 raM) to protect he enz~,me. 
Once the enzyme was incubated with Ca :+ and hpids, it wa~ converted 
to a lipoproteln form which no longer required further addition of 
Ca ~ and hpids for expressm/~ the kinase activity This lipid-treated 
PKC when assayed in the absence of added Ca -'~ and lipids, exhibited 
nearly 60 to 80% of the optimal actiwty obtained by incubating with 
Ca:* and lipids. Hence the total aetiv=.ty observed with Ca 2~ and lipids 
was presented without ~ubtraetmg the Ca~*/lipid-indepeadent basal 
aetLvay, After separation of calphostm C from the treated PKC sam- 
ples, both kinase activity and PDBu bmding of PKC were determined 
by multiwell filtration assays The values represent mean of three 
replicate stimations. 
to unders tand  the mechan ism of  the ca lphost in  C effect 
on PKC,  initially PKC was treated with ca lphost in  C 
under  def ined condit ions,  and  tbcn  calphostir~ C was 
removed f rom the treated PKC sample.  Thus ,  at a later 
step dur ing  the determinat ion  o f  k inase activity and  
PDBu binding,  ca lphost in  C was no  longer  present.  
3.1. Ca 2. requirement fo r  PKC modification by cal- 
phostbz C 
Init ial ly PKC was incubated under  laboratory  f luo- 
rescent l ight with ca lphost in  C (0 .01-1 / . tM)  for  3 min  
in the presence o f  1 mM EGTA.  A f te r  remov ing  the 
ca lphost in  C0 the treated PKC samples were analyzed,  
and there was no decrease in either k inase activity or 
PDBu binding.  On  the cont rary ,  when PKC was incu-  
bated with ca lphost in  C in the presence o f  Ca  2., PKC 
lost i rreversibly both  k inase activity and PDBu binding.  
The  opt ima l  concent ra t ion  o f  Ca 2~ requi red was in the 
range o f  1-1.5 mM (Fig. 1). However ,  in the presence 
o f  phosphat idy lser ine  and  diolein the Ca  ~* required for  
ca!phost in  C -med ia ted  inaetiw~tion was decreased to  as 
low as 1 /aM. Nonetheless ,  no inact ivat ion  was noted  
with these l ipids in the presence o f  1 mM EGTA.  Si~vd- 
larly, TPA  a long with phosphat idy l~er ine also de-  
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Fig, 2 The oxygen leqmrement for PKC inactivation by calphostm 
C, These PKC modifieation~ were carried out in the absence of lipids 
in microfuge tubes fitted w~th rubber stopperb To two sets of PKC 
samples, md~cated concentrations of calphostm C were added along 
with 1 mM EGTA, One set of samples (open symbols) wa~ left in 
normal atmospheric all', whereas m the other set of santples (closed 
~ymbolb) air was displa~d with nitrogen 8a~, To m~tmte PKC modifi- 
cation, CaCI. wa~ injected to both sets of ~amples toobtain 1 mM free 
Ca '+. Then the samples were incubated fm 3 n~n in the presence of 
light and EGTA was added to a final concentlation of 5 raM. Both 
PKC activity and PDBu blndin8 were determined in the treated sam- 
ple~, 
creased the requirement of Ca 2+ for PKC inactivation. 
PKC activity did not recover by subjecting the cal- 
phostin C-inactivated PKC to extensive diai2isis, to hy- 
drophobic chromatography, or to DEAE-cellulose 
chromatography. Conceivably, the observed ecrease in
PKC activity was due to the irreversible modification of 
PKC induced by calphostin C. 
3.2. Oxygen requh'ement forphoto-inactivation 
Since the caiphostin C-mediated inactivation of PKC 
was a light-dependent reaction, we tested whether any 
oxidations were involved in this inactivation. As shown 
in Fig. 2, although ealphostin C inactivated PKC in the 
presence of normal atmospheric air (presence of oxy- 
gen), under a complete nitrogen atmosphere (absence of 
oxygen) it failed to inactivate PKC even at a higher 
concentration (1 /~M). This suggested that calphostin 
C-mediated inactivation of PKC involves oxidation(s). 
3.3. The reqttiremettt of Ca:÷-hzduced accessible hydro- 
phobic site 
Based on our previous observations that Ca:* induced 
the hydrophobic reaction on PKC [21] and also Ca 2÷ 
was required for calphostin C-mediated PKC inactiva- 
tion as shown in the present study, we assessed whether 
the Ca'-*-indaced hydrophobic site may be required for 
this inactivation. For this purpose we used two prepara- 
tions of PKC that exhibited a differential sensitivity to 
calphostin C-mediated inactivation. PKC in freshly pu- 
rified preparations from rat brain was inactivated by 
calphostin C above 95%, whereas the preparation of 
PKC purified and stored for 3 months at -20°C was 
inactivated only 50-70% by calphostin C. PKC exhibits 
two types of binding to phenyi-Sepharose: one is a Ca -~÷- 
independent weak hydrophobic binding which requires 
a high ionic strelzgth (0.5 M NaCI), whereas the later 
type is a Ca-'+-induced binding, which is stronger and 
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Fig. 3 Effect ofcalphostm C on the purified PKC that Ca ~'-dependently retained on tile phenyl-Sepkarose column. (A) Purifi~'d PKC used within 
two days after i~olation from fresh rat brain~. (B) Purified PKC preparation sto.~,d for 3 montb~ at -20°C PKC samples (2 ml) were apphed to 
a I ml phc0yl-,qepharo~¢ coh,mn prewously ex!u=hbrated with buffer A containmL~ 0.5 M NaCl and allowed to Ca-'*-independently brad to the re~in 
by washing with the same buffer. Then the column was washed with buffer A containing l mM CaCl, in place of l mM EDTA. Then the 
Caa*-dependently bound PKC was eluted with 5 mM EGTA Fraction~ of l ml were collected, and ~ubdivided into two portions. One ~¢t of 
sabfi actlon~ were treated with ealphostin C. Then PKC activity pre~ent in all these ~ubfraetions was determined after removing calphostin C. (e - -~)  
PKC activity in .~ubfractions ,not treated with calphostin C; (o--<3) PKC activ, ty in sabfractlons treated wzth calphostin C, 
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FiB. 4. Inactivation of PKC in intact cells treated with calphostm C. 
Confluent C6 glioma cells ware treated with calphostm C (0.5/aM) for 
the mdtcat~d time periods. Then both the cytosoiic and detcrsent- 
nolabdized membrane fractions wore prepared and PKC activity was 
determined after isolation by DEAE-eoIIuloso ehromatograph~,. 
can occur even in a low-ionic-strength buffer (without 
~alt). The Ca2÷-induced hydrophobia region on PKC in 
both fresh and stored preparations was evaluated by 
Ca2~'-dependent retention of PKC on phenyl-Sepharose 
in a low-ionic-strength buffer. PKC activity present in 
both preparations was completely bound Ca2~-inde - 
pendently to phenyl-Sepharose at a high-ionic-strength 
buffer (0.5 M l'qaC1). Furthermore, most of the (95%) 
activity of freshly purified PKC was Ca2~-dependently 
retained on the phenyl-Sepharose when the bound en- 
zyme was washed with a low-ionic-strength buffer con- 
taining 1 mM CaCIa (Fig. 3A), while with the stored 
enzyme, only 55% of the activity was retained under 
these conditions (Fig. 3B). Approximately 40% of the 
stored PKC, although it had both kinase activity and 
PDBtt binding, did not retain Ca 2~-dependently with 
pherxyl-Sepharose when the column was washed with a 
low-ionic-strength buffer with CaCI,. Thus, the Ca 2÷- 
independent weak hydrophobic region on PKC was not 
affected by storage, while a fraction (40%) of the PKC 
molecules in the stored preparation ;o,,t the ability to 
expose the strong hydrophobic site in the presence of 
Ca ~-+. Only the fraction of PKC exhibiting the Ca 2"- 
induced hydrophobic site was inactivated by calphostin 
C, whereas the fraction of  PKC that did not exhibit a 
Cane-induced hydrophobia site was resistant o cal- 
phostin C inactivation. Moreover, the calpain-digested 
PKC (M-kinase) that lacked the Ca 2~-induced hydro- 
phobic region was not inactivated by calphostin C. 
Some proteins, such as hemoglobin° have been shown 
to undergo Jt'a~aaex~tatxon upor, exposure to o~idants 
[22]. However, calphostin C-treated PKC showed no 
decrease in molecular weight as judged by SDS/poly- 
acrylamide electrophoresis. Nonetheless, the inae- 
tivated PKC failed to bind phenyl-Sepharose in a low- 
ionic-strength buffer when it was monitored by im- 
munoblotting. This suggests that the Ca2*-induced hy- 
drophobic region on PKC is required to mediate and is 
also affected by a calphostin C-induced modification of 
PKC. Whether there was any formation of covalent 
adducts of calphostin C with PKC during photoexcita- 
tion was evaluated. Since calphostin C is a bright red 
compound, the visible absorption spectrum of the cal- 
phostin C-treated PKC (0.8 rag, 10 nmol) was deter- 
mined. There was no detectable amount ofchromogcnic 
material associated with the calphostin C-treated PKC 
after it was subjected to a centrifuge column technique. 
This suggested that if there was any low (nonstoichiom- 
attic) amount ofcalphostin C covalently associated with 
PKC below the limits of detection (<1 nmol), it was 
unlikely to be responsible for the observed total loss of 
PKC activity. 
3.4. Possible b~volvement of ainglet oxygen in the site- 
specific o.xidatit,e htactivation of PKC by calphostm 
C 
Since photoexcitation of perylenequinones was 
shown to generate singlet oxygen [23], the possible in- 
volvement of singlet oxygen in PKC inactivation was 
evaluated. Initially the calphostin C alone was exposed 
to light and then light-treated calphostin C was added 
to PKC in the dark. This two-step treatment did not 
produce any inactivation of PKC. Simultaneous expo- 
sure of PKC and calphostin C to light was required to 
induce the inactivation of PKC. Then, both physical 
and chemical quenchers of singlet oxygen [24] were 
tested to inhibit calphostin C-mediated inactivation of 
PKC. Hydrophobic physical quenchers of singlet oxy- 
gen such as lycopene (10/.tM), fl-carotcne (10 ,aM), and 
t~-tocopherol (50 ,aM) substantially (80--90%) decreased 
the inactivation of PKC b2¢ calphostin C (Table 1). 
However, hydrophilic hemical quenchers_such as N- 
acetylcysteine, 2-mercaptoethanol r dith--]-~h-~i~l 
Table I
F_.ff~t of physical and chemical quenchers of stag, let oxyg, en on the 
calphostm C-mad,areal inactivation of PKC 
Treatment PKC activity PDBa binding 
(units) (pmoi) 
Control untreated 1 96 
Calphostm C (I gM) alone 0.29 
Calpho~tm C (1 ,~tM) along with 
quenchers of slnslet oxygen 
LTcopene (10/tM) 1 74 
fl-Carotene ( 10//M) 1.67 
a-Tocopherol (50 ,aM) 1.64 
N-Acetylcysteinc (5 mM) 0.27 
2-Mercaptoethanol (5 raM) 0 26 
Dithiothreitol (5 raM) 0.24 
24.2 
3.1 
21.2 
20.8 
19.9 
28 
2.4 
2.2 
The~e calphostm C-mediated PKC modifications were carried out m 
the presence of l mM free Ca z~ and in the absence of lipids. 
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failed to inhibit the inactivation of PKC by calphostin 
C even at a very high (5 mM) concentration. The protec- 
tion offered by carotenoids and tocopherol was unlikely 
due to the competition &these hydrophobic agents with 
calphostin C for the binding site on PKC0 since the 
nonspecific hydrophobic agents such as adriamycin 
(100 gM), phosphatidylserine and other phospholipids 
(20/.tg/mt) failed to protect PKC from calphostin C- 
mediated inactivation. 
Calphostin C at a 100-500-fold higher (20-100/,tM) 
concentration i activated PKC in a Ca2"-independent 
manner. This inactivation of PKC at higher concentra- 
tions of calphostin C was prevented by water-soluble 
thiol agents as well as hydrophobic singlet oxygen 
quenchers. It is possible that at low (nanomolar) con- 
centrations of calphostin C, the amounts of reactive 
oxygen species formed may be too low to induce the 
oxidative modification of PKC. Nevertheless, in the 
presence of Ca'-*, calphostin C may bind initially to the 
Ca2+-indueed hydrophobic site. Then the reactive oxy- 
gen species generated from this protein-bound cal- 
phostin C by a ligh reaction may selectively modify the 
oxidation susceptible amino acid residue(s) present 
within the vicinity. Since such an oxidative modification 
is a 'cage' type reaction, the externally added thiol 
agents cannot quench the oxidant formed from the pro- 
tein-bound ligand. However, the hydrophobic quench. 
ers of singlet oxygen (carotenoids and tocopheroi) may 
bind to a hydrophobic site in the near vicinity of the 
calphostin C-binding region and thereby have the access 
to trap reactive oxygen species formed. On the contrary, 
at higher concentrations (,uM) of caiphostin C, the con- 
¢entration of reactive oxygen species generated may be 
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Fig, 5. El'feet of TPA pretreatmcnt on the ,zalphostm C-mediated 
inaetl, ation of PKC in intact cells. Conlluent C6 glioma cells were 
treated inltmlly with TPA (100 nM) fo~ 30 ham to reduce a cytosol to 
membrane transloeatton of PKC Then both control and TPA-treatexl 
ceils were incubated with calphostln C (0.5/aM) in the presence l'light 
for indicated time periods. Then, total PKC (eytosol and membrane) 
was extracted from the cells with a buffer containing detergent and 
PKC aetiwty was determined as described m section 2. 
high enough to induce nonspgcific modifications in the 
PKC molecule resulting in the inactivation of the en- 
zyme in a manner similar to that observed with H20., 
and N-chlorosuccinimide [6,7]. Since under these condi- 
tions the oxidants are generated externally to the pro- 
tein, both water-soluble ar.d hydrophobie quenchers 
could prevent he oxidative modification of PKC. 
3.5. [nactit,ation of  PKC m intact cells 
Treatment of C6 glioma cells with calphostin C (0.1 
and 1 gM) in the presence of light resulted in a loss of 
both kinase activity and PDBn binding. This inactiva- 
tion of PKC was rapid in the membrane fraction com- 
pared to cytosoi (Fig. 4). Furthermore, prior treatment 
with TPA (100 nM) to induce membrane association of 
PKC resulted in a more rapid inactivation of PKC com- 
pared to that of cells treated with ealphostin C alone 
(Fig. 5). In all these cases the PKC activity was not 
recovered by an incubation with 5 raM DTT. We then 
tested whether the removal of calphostin C from the 
treated cells could result in the recovery of PKC to an 
active form. C6 glioma cells were initially treated with 
calphostin C (0.1 pM) for 2 h and then the treated cells 
were washed twice with Hunk's balanced salt solution 
and twice with DMEM medium. The washed cells were 
kept in fresh medium with no caiphostin C. Similarly 
treated and washed cells were left in a medium with 
cycloheximide (10,u/ml) to prevent protein synthesis. In 
the cells where protein ~ymhesis was allowed, PKC was 
returned to the control evel within 12 h. However, in 
the cells where protein synthesis was inhibited by cyclo- 
heximide, no recovery of PKC activity was observed 
(data not shown). This suggested that PKC was inac- 
tivated irreversibly in the cells and the PKC protein was 
not repaired by any intracellular mechanisms operating 
in the cell. 
4. DISCUSSION 
The currently characterized oxidative modification of 
PKC induced by calphostin C is different from our 
previously revealed PKC modifications induced by oxi- 
dant tumor promoters uch as H~.O2 and m-periodate 
[6-8] in at least four aspects. First, the inactivation of 
PKC induced by calphoztin C at nanomolar concentra- 
tions is stricly a Ca2÷-dependent process, whereas the 
niodifications induced by H202 and m-periodate are not 
strictly Ca:+-dependent, which however are enhanced 
by Ca 2'. Second, there is no transient formation of an 
oxidatively activated Ca-~*/lipid-independent form of 
PKC during modification by calphostin C. Third, m- 
periodate and H20~. require higher (/~M to raM) concen- 
trations to induce oxidative modi0cation ofPKC. How- 
ever, ealphostin C, by initially binding to the Ca2+-in - 
duced hydrophobie site on PKC, and then undergoing 
photo-oxidation can induce a site-specific modification 
even at lower (nanomolar) concentrations. Finally, the 
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modifications of PKC induced by externally added oxi- 
dants are inhibited by thiol agents, whereas the modifi- 
cation of  PKC induced by calphostin C is not inhibited 
by thiol agents. 
Ca2+-indttced accessible hydrophobi¢ ~ites are also 
present in other proteins such as calmodulin, calpains, 
S-100 protein, troponin C and other related Ca2÷-regu - 
iated proteins [21,25,26]. It would be interesting to 
know whether ealphostin C also could affect these pro. 
teins. Although calphostiu C is often referred to as an 
inhibitor of PKC, to distinguish it from other inhibitors 
CD%'~-%k~ suc'~ ashh-"~, shaurD~.~t~me, e'n~herytnfm~o anb 
sphingosine, which bind to and reversibly inhibit PKC, 
it should be treated as an irreversible inactivator of 
~KC.  The irreversible mactivattort or" PKC may bring 
prolonged effects (hours) on the cells treated with eal- 
phostin C for a limited time. This information on irre- 
versible inactivation may further help in cnperimcntal 
~e~ u~m~ cah.~'n~sYm ~ ~s a 2D'~arma~ohD~h~ah "~t~t~h 
such as calphostin C may be useful in photodynamie 
therap2~, 
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